Ruizhan Tong

1.3k total citations
20 papers, 450 citations indexed

About

Ruizhan Tong is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ruizhan Tong has authored 20 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Ruizhan Tong's work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). Ruizhan Tong is often cited by papers focused on CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). Ruizhan Tong collaborates with scholars based in China, United States and Canada. Ruizhan Tong's co-authors include You Lü, Jianxin Xue, Mengqian Li, Yuncong Liu, Liting You, Limei Yin, Li Wu, Zhuoran Yao, Limei Yin and Yue Zheng and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Pharmacology.

In The Last Decade

Ruizhan Tong

20 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruizhan Tong China 11 211 203 91 75 68 20 450
Liting You China 9 182 0.9× 152 0.7× 73 0.8× 65 0.9× 63 0.9× 25 412
Yingxiao Chen China 14 300 1.4× 129 0.6× 127 1.4× 89 1.2× 58 0.9× 24 630
Giulia Scotto Italy 10 177 0.8× 242 1.2× 99 1.1× 99 1.3× 106 1.6× 19 458
Carolynn E. Ohlson United States 5 355 1.7× 353 1.7× 213 2.3× 77 1.0× 64 0.9× 6 640
Angela M. Araujo Spain 7 249 1.2× 145 0.7× 110 1.2× 194 2.6× 55 0.8× 9 468
Laia Gorchs Sweden 10 136 0.6× 281 1.4× 296 3.3× 56 0.7× 21 0.3× 13 520
Meihong Wu China 11 167 0.8× 144 0.7× 50 0.5× 106 1.4× 65 1.0× 21 362

Countries citing papers authored by Ruizhan Tong

Since Specialization
Citations

This map shows the geographic impact of Ruizhan Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruizhan Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruizhan Tong more than expected).

Fields of papers citing papers by Ruizhan Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruizhan Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruizhan Tong. The network helps show where Ruizhan Tong may publish in the future.

Co-authorship network of co-authors of Ruizhan Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Ruizhan Tong. A scholar is included among the top collaborators of Ruizhan Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruizhan Tong. Ruizhan Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tong, Ruizhan, et al.. (2025). NSUN2 Knockdown Promotes the Ferroptosis of Colorectal Cancer Cells Via m5C Modification of SLC7A11 mRNA. Biochemical Genetics. 64(1). 524–537. 3 indexed citations
2.
Zheng, Yue, Pengfei Zhou, Hui Wang, et al.. (2025). Stimulator of Interferon Genes Agonist Synergistically Amplifies Programmed Cell Death Protein-1 Blockade and Radiation-Induced Systemic Antitumor Responses via Tumor Microenvironment Enrichment. International Journal of Radiation Oncology*Biology*Physics. 123(2). 536–549. 1 indexed citations
3.
4.
Zheng, Yue, Limei Yin, Zhuoran Yao, et al.. (2022). Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies. Frontiers in Oncology. 12. 873994–873994. 63 indexed citations
5.
Xiong, Qiuchan, Xin Zheng, Xinyi Zhou, et al.. (2022). METTL3-mediated m6A RNA methylation regulates dorsal lingual epithelium homeostasis. International Journal of Oral Science. 14(1). 26–26. 8 indexed citations
6.
Wu, Yang, Miao Yang, Jin Yang, et al.. (2021). Ionizing radiation‐induced “zombie” carcinoma‐associated fibroblasts with suppressed pro‐radioresistance on OSCC cells. Oral Diseases. 29(2). 563–573. 9 indexed citations
7.
Li, Rui, Yuncong Liu, Rutie Yin, et al.. (2021). The Dynamic Alternation of Local and Systemic Tumor Immune Microenvironment During Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 110(5). 1432–1441. 28 indexed citations
8.
Yin, Limei, Jianxin Xue, Lin Zhou, et al.. (2020). Effect Of Low-Dose Radiotherapy On Abscopal Responses To Hypofractionated Radiotherapy And Anti-PD1 In Mice and NSCLC Patients. International Journal of Radiation Oncology*Biology*Physics. 108(3). e563–e563. 3 indexed citations
9.
Liu, Yuncong, Li Wu, Ruizhan Tong, et al.. (2019). PD-1/PD-L1 Inhibitors in Cervical Cancer. Frontiers in Pharmacology. 10. 65–65. 117 indexed citations
10.
You, Liting, Ruizhan Tong, Mengqian Li, et al.. (2019). Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research. Molecular Therapy — Methods & Clinical Development. 13. 359–370. 80 indexed citations
11.
Yin, Limei, Xiaojuan Zhou, Ruizhan Tong, et al.. (2018). Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancer. Journal of Thoracic Disease. 10(2). 816–824. 11 indexed citations
12.
Yin, Limei, Jianxin Xue, Feifei Na, et al.. (2018). PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy. Biomedicine & Pharmacotherapy. 99. 615–621. 11 indexed citations
13.
Lü, You, Jianxin Xue, Tao Deng, et al.. (2018). A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer.. Journal of Clinical Oncology. 36(15_suppl). 3050–3050. 26 indexed citations
14.
Yin, Limei, Jie Lan, Ruizhan Tong, et al.. (2018). Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer. Cancer Science. 109(7). 2243–2255. 13 indexed citations
15.
Wu, Yalan, Ruizhan Tong, Yan Zhang, et al.. (2017). Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC. OncoTargets and Therapy. Volume 10. 3307–3312. 10 indexed citations
16.
Chen, Baoqing, Feifei Na, Hui Yang, et al.. (2017). Ethyl pyruvate alleviates radiation-induced lung injury in mice. Biomedicine & Pharmacotherapy. 92. 468–478. 28 indexed citations
17.
Chen, Baoqing, Lu Gan, Jingwen Wang, et al.. (2017). FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients. Cancer Biology & Therapy. 19(1). 76–86. 18 indexed citations
18.
Li, Rui, Guo Chen, Lin Zhou, et al.. (2017). The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced Lung Injury in a Mouse Model. Inflammation. 40(4). 1254–1263. 6 indexed citations
19.
Wu, Yalan, Ruizhan Tong, Yan Zhang, et al.. (2017). Detecting T790M mutation of tissue and plasma ctDNA samples by ARMS in EGFR-mutant NSCLC patients after disease progression.. Journal of Clinical Oncology. 35(15_suppl). e20625–e20625. 2 indexed citations
20.
Hong, Jin, et al.. (1999). Simultaneous dual-wavelength operation in cascaded strongly gain-coupled DFB lasers. IEEE Photonics Technology Letters. 11(11). 1354–1356. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liting You Breakdown of academic impact, for papers by Yingxiao Chen Breakdown of academic impact, for papers by Giulia Scotto Breakdown of academic impact, for papers by Carolynn E. Ohlson Breakdown of academic impact, for papers by Angela M. Araujo Breakdown of academic impact, for papers by Laia Gorchs Breakdown of academic impact, for papers by Meihong Wu
Rankless by CCL
2026